AT(2)Rs [AngII (
angiotensin II) type 2 receptors] contribute to the cardioprotective effects of
angiotensin II receptor blockers, possibly via
kinins acting on the B(1)R (B(1) receptor) and
B(2)R (
B(2) receptor). Recent studies have shown that a lack of
B(2)R up-regulates B(1)R and AT(2)R; however, the pathophysiological relevance of such an event remains unclear. We hypothesized that up-regulation of AT(2)R and B(1)R compensates for the loss of
B(2)R. Blockade of AT(2)R and/or B(1)R worsens cardiac remodelling and dysfunction following MI (
myocardial infarction) in
B(2)R(-/-) (B(2)-receptor-knockout mice).
B(2)R(-/-) mice and WT (wild-type) controls were subjected to
sham MI or MI and treated for 4 weeks with (i) vehicle, (ii) a B(1)R-ant (B(1)R antagonist; 300 μg/kg of
body weight per day), (iii) an AT(2)R-ant [AT(2) receptor antagonist (
PD123319); 20 mg/kg of
body weight per day], or (iv) B(1)R-ant+AT(2)R-ant.
B(2)R(-/-) mice had a greater MCSA (myocyte cross-sectional area) and ICF (interstitial
collagen fraction) at baseline and after MI compared with WT controls. Cardiac function and increase in macrophage infiltration, TGFβ(1) (
transforming growth factor β(1)) expression and ERK1/2 (
extracellular-signal-regulated kinase 1/2) phosphorylation post-MI were similar in both strains. Blockade of AT(2)R or B(1)R worsened cardiac remodelling,
hypertrophy and dysfunction associated with increased
inflammation and ERK1/2 phosphorylation and decreased NO excretion in
B(2)R(-/-) mice, which were exacerbated by dual blockade of B(1)R and AT(2)R. No such effects were seen in WT mice. Our results suggest that, in the absence of
B(2)R, both B(1)R and AT(2)R play important compensatory roles in preventing deterioration of cardiac function and remodelling post-MI possibly via suppression of
inflammation, TGFβ(1) and ERK1/2 signalling.